The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression

The effectiveness of the esketamine nasal spray (ESK-NS) for treatment-resistant depression (TRD) has been confirmed by real-world studies. Available evidence derived from clinician-rated assessments might differ from patients’ perceptions about the helpfulness of treatments. We aimed to verify the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepe, Maria, Bartolucci, Giovanni, Marcelli, Ilaria, Pesaresi, Francesco, Brugnami, Andrea, Caso, Romina, Fischetti, Alessia, Grisoni, Flavia, Mazza, Marianna, Camardese, Giovanni, Di Nicola, Marco, Sani, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604956/
https://www.ncbi.nlm.nih.gov/pubmed/37891860
http://dx.doi.org/10.3390/brainsci13101494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604956/
https://www.ncbi.nlm.nih.gov/pubmed/37891860
http://dx.doi.org/10.3390/brainsci13101494

Ejemplares similares